Stock Analysis

The 13% return this week takes Ind-Swift Laboratories' (NSE:INDSWFTLAB) shareholders three-year gains to 202%

NSEI:INDSWFTLAB
Source: Shutterstock

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a really great company, you can more than double your money. To wit, the Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) share price has flown 202% in the last three years. That sort of return is as solid as granite. On top of that, the share price is up 25% in about a quarter.

The past week has proven to be lucrative for Ind-Swift Laboratories investors, so let's see if fundamentals drove the company's three-year performance.

See our latest analysis for Ind-Swift Laboratories

SWOT Analysis for Ind-Swift Laboratories

Strength
  • No major strengths identified for INDSWFTLAB.
Weakness
  • Earnings declined over the past year.
  • Interest payments on debt are not well covered.
Opportunity
  • Trading below our estimate of fair value by more than 20%.
  • Lack of analyst coverage makes it difficult to determine INDSWFTLAB's earnings prospects.
Threat
  • Debt is not well covered by operating cash flow.

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

Ind-Swift Laboratories became profitable within the last three years. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

earnings-per-share-growth
NSEI:INDSWFTLAB Earnings Per Share Growth May 30th 2023

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

A Different Perspective

It's nice to see that Ind-Swift Laboratories shareholders have received a total shareholder return of 40% over the last year. That gain is better than the annual TSR over five years, which is 1.4%. Therefore it seems like sentiment around the company has been positive lately. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Case in point: We've spotted 4 warning signs for Ind-Swift Laboratories you should be aware of, and 1 of them is significant.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Indian exchanges.

Valuation is complex, but we're helping make it simple.

Find out whether Ind-Swift Laboratories is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.